Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancer Ruchika Sharma7 Sept 2025 4:15 PM ISTIndianapolis: Eli Lilly and Company has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for...
India faces rising cancer burden, Bengaluru Women Most Affected: Study Anshika Mishra3 Sept 2025 5:30 PM ISTA large cross-sectional study has revealed significant regional disparities in cancer incidence across India and an overall rising cancer burden. The...
Health Bulletin 03/September/2025 Anshika Mishra3 Sept 2025 5:02 PM ISTHere are the top health stories of the day:Kerala HC issues draft guidelines for Medical Negligence CasesThe Kerala High Court recently passed a...
Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million Ruchika Sharma2 Sept 2025 11:45 AM ISTNew York: Royalty Pharma plc has announced that the company has acquired a royalty interest in Amgen's Imdelltra, a first-in-class DLL3 targeting...
Boehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant advanced NSCLC Ruchika Sharma2 Sept 2025 10:50 AM ISTBoehringer Ingelheim has received approval for HERNEXEOS (zongertinib tablets) from China's National Medical Products Administration (NMPA) as...
Cancer Burden Analysis Across 43 Cancer Registries in India: 5 Key Highlights Dr Jeegar Dattani28 Aug 2025 7:00 AM ISTA large cross-sectional study has revealed significant regional disparities in cancer incidence across India and an overall rising cancer burden. The...
New guideline offers menu of options to help people quit smoking tobacco Dr. Kamal Kant Kohli26 Aug 2025 9:00 PM ISTTobacco smoking is the number one cause of preventable disease and death in Canada; it is highly addictive and hard to stop. Recognizing these...
Double Relief: Study evaluates Synergistic Effects of Hydromorphone and Ropivacaine in Thoracoscopic Surgery Dr Monish Raut19 Aug 2025 8:15 PM ISTRecently published clinical trial aimed to evaluate the efficacy of hydromorphone as an adjunct to ropivacaine in serratus anterior plane block (SAPB)...
Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer Ruchika Sharma19 Aug 2025 2:15 PM ISTPrinceton: SystImmune Inc., a clinical-stage biotechnology company, and Bristol Myers Squibb have announced that the U.S. Food and Drug...
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer Ruchika Sharma19 Aug 2025 12:30 PM ISTRahway: Merck and Daiichi Sankyo have announced that Ifinatamab deruxtecan (I-DXd) has been granted Breakthrough Therapy Designation (BTD) by the...
Medical Bulletin 13/August/2025 Dr. Bhumika Maikhuri13 Aug 2025 3:00 PM ISTHere are the top medical news for the day:5 Lifestyle Habits May Cut Heart Disease Risk by 86% in Women with Gestational DiabetesA study published in...
Thermo Fisher gets USFDA nod for NGS-based Companion Diagnostic for new Non Small Cell Lung Cancer treatment Ruchika Sharma13 Aug 2025 5:40 PM ISTCarlsbad: Thermo Fisher Scientific has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a...
